Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurol
    October 2022
  1. FERNANDES M, Mari L, Chiaravalloti A, Paoli B, et al
    (18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
    J Neurol. 2022;269:5356-5367.
    >> Share

    September 2022
  2. ACHENBACH J, Faissner S, Saft C
    Resurrection of sildenafil: potential for Huntington's Disease, too?
    J Neurol. 2022;269:5144-5150.
    >> Share

  3. RHODUS EK, Barber J, Kryscio RJ, Abner EL, et al
    Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia.
    J Neurol. 2022;269:5105-5113.
    >> Share

  4. ALTUNA M, Larumbe R, Zelaya MV, Moreno S, et al
    Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    J Neurol. 2022;269:4853-4862.
    >> Share

    August 2022
  5. SINGH NA, Graff-Radford J, Machulda MM, Schwarz CG, et al
    Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.
    J Neurol. 2022 Aug 24. pii: 10.1007/s00415-022-11330.
    >> Share

  6. DOUNAVI ME, Newton C, Jenkins N, Mak E, et al
    Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
    J Neurol. 2022;269:4299-4309.
    >> Share

    July 2022
  7. MENARDI A, Dotti L, Ambrosini E, Vallesi A, et al
    Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization.
    J Neurol. 2022 Jul 4. pii: 10.1007/s00415-022-11236.
    >> Share

  8. LAFORCE RJ, Dallaire-Theroux C, Racine AM, Dent G, et al
    Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.
    J Neurol. 2022;269:3579-3587.
    >> Share

  9. ROSENBLUM Y, Shiner T, Bregman N, Fahoum F, et al
    Event-related oscillations differentiate between cognitive, motor and visual impairments.
    J Neurol. 2022;269:3529-3540.
    >> Share

    June 2022
  10. CLARK E, Faruque S, Mutebi C, Nagirimadugu NV, et al
    Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias: a systematic review.
    J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11186.
    >> Share

    March 2022
  11. ISELLA V, Crivellaro C, Formenti A, Musarra M, et al
    Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
    J Neurol. 2022 Mar 26. pii: 10.1007/s00415-022-11086.
    >> Share

  12. GIACOMUCCI G, Mazzeo S, Bagnoli S, Ingannato A, et al
    Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    J Neurol. 2022 Mar 14. pii: 10.1007/s00415-022-11055.
    >> Share

  13. BANERJEE G, Forsgard N, Ambler G, Keshavan A, et al
    Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
    J Neurol. 2022;269:1470-1475.
    >> Share

    February 2022
  14. CORRIVEAU-LECAVALIER N, Machulda MM, Botha H, Graff-Radford J, et al
    Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.
    J Neurol. 2022 Feb 25. pii: 10.1007/s00415-022-11025.
    >> Share

    January 2022
  15. LARDEUX P, Fourier A, Peter E, Dorey A, et al
    Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis.
    J Neurol. 2022;269:377-388.
    >> Share

    December 2021
  16. SCHUMACHER J, Taylor JP, Hamilton CA, Firbank M, et al
    Functional connectivity in mild cognitive impairment with Lewy bodies.
    J Neurol. 2021;268:4707-4720.
    >> Share

  17. SANTORO JD, Pagarkar D, Chu DT, Rosso M, et al
    Neurologic complications of Down syndrome: a systematic review.
    J Neurol. 2021;268:4495-4509.
    >> Share

    November 2021
  18. ROSSO M, Chu D
    Gaetano Perusini (1879-1915).
    J Neurol. 2021;268:4400-4401.
    >> Share

    October 2021
  19. CONTADOR J, Perez-Millan A, Guillen N, Tort-Merino A, et al
    Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease.
    J Neurol. 2021 Oct 19. pii: 10.1007/s00415-021-10851.
    >> Share

  20. PLEEN J, Townley R
    Alzheimer's disease clinical trial update 2019-2021.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10790.
    >> Share

  21. ARMON C, Wolfson S, Margalit R, Avraham L, et al
    Estimating the X chromosome-mediated risk for developing Alzheimer's disease.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10826.
    >> Share

  22. OLIVIERI P, Lebouvier T, Hardouin JB, Courtemanche H, et al
    LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders.
    J Neurol. 2021;268:3886-3896.
    >> Share

    July 2021
  23. ULUGUT H, Stek S, Wagemans LEE, Jutten RJ, et al
    The natural history of primary progressive aphasia: beyond aphasia.
    J Neurol. 2021 Jul 3. pii: 10.1007/s00415-021-10689.
    >> Share

    June 2021
  24. MOHAMED AZ, Nestor PJ, Cumming P, Nasrallah FA, et al
    Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    J Neurol. 2021 Jun 30. pii: 10.1007/s00415-021-10669.
    >> Share

    May 2021
  25. LIU X, Dounavi ME, Ritchie K, Wells K, et al
    Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.
    J Neurol. 2021;268:1962-1971.
    >> Share

    April 2021
  26. WEI Y, Liu M, Wang D
    The propagation mechanisms of extracellular tau in Alzheimer's disease.
    J Neurol. 2021 Apr 28. pii: 10.1007/s00415-021-10573.
    >> Share

  27. FIRBANK MJ, O'Brien JT, Durcan R, Allan LM, et al
    Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.
    J Neurol. 2021;268:1284-1294.
    >> Share

    January 2021
  28. ORAD RI, Shiner T
    Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
    J Neurol. 2021 Jan 29. pii: 10.1007/s00415-021-10402.
    >> Share

  29. SEGHEZZO G, Van Hoecke Y, James L, Davoren D, et al
    Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.
    J Neurol. 2021 Jan 26. pii: 10.1007/s00415-021-10403.
    >> Share

    August 2020
  30. SMEDINGA M, Darweesh SKL, Bloem BR, Post B, et al
    Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field.
    J Neurol. 2020 Aug 18. pii: 10.1007/s00415-020-10162.
    >> Share

  31. TORSO M, Ahmed S, Butler C, Zamboni G, et al
    Cortical diffusivity investigation in posterior cortical atrophy and typical Alzheimer's disease.
    J Neurol. 2020 Aug 8. pii: 10.1007/s00415-020-10109.
    >> Share

    July 2020
  32. JISKOOT LC, Poos JM, Vollebergh ME, Franzen S, et al
    Emotion recognition of morphed facial expressions in presymptomatic and symptomatic frontotemporal dementia, and Alzheimer's dementia.
    J Neurol. 2020 Jul 29. pii: 10.1007/s00415-020-10096.
    >> Share

  33. ANDRIUTA D, Perron A, Roussel M, Godefroy O, et al
    Comment on: "Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis".
    J Neurol. 2020 Jul 8. pii: 10.1007/s00415-020-10036.
    >> Share

  34. DAVDA N, Corkill R
    Biomarkers in the diagnosis and prognosis of Alzheimer's disease.
    J Neurol. 2020 Jul 7. pii: 10.1007/s00415-020-10037.
    >> Share

    June 2020
  35. KOLANKO M, Win Z, Patel N, Malik O, et al
    Using amyloid PET imaging to diagnose Alzheimer's disease in patients with multiple sclerosis.
    J Neurol. 2020 Jun 18. pii: 10.1007/s00415-020-09969.
    >> Share

  36. VOGLEIN J, Ricard I, Noachtar S, Kukull WA, et al
    Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.
    J Neurol. 2020 Jun 2. pii: 10.1007/s00415-020-09937.
    >> Share

    May 2020
  37. DONAGHY PC, Firbank M, Mitra D, Petrides G, et al
    Microbleeds in dementia with Lewy bodies.
    J Neurol. 2020;267:1491-1498.
    >> Share

    March 2020
  38. IIZUKA T, Kameyama M
    Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    J Neurol. 2020 Mar 13. pii: 10.1007/s00415-020-09790.
    >> Share

    December 2019
  39. WEI G, Irish M, Hodges JR, Piguet O, et al
    Disease-specific profiles of apathy in Alzheimer's disease and behavioural-variant frontotemporal dementia differ across the disease course.
    J Neurol. 2019 Dec 23. pii: 10.1007/s00415-019-09679.
    >> Share

  40. GAETA AM, Benitez ID, Jorge C, Torres G, et al
    Prevalence of obstructive sleep apnea in Alzheimer's disease patients.
    J Neurol. 2019 Dec 12. pii: 10.1007/s00415-019-09668.
    >> Share

  41. KLOTH N, Lemke J, Wiendl H, Meuth SG, et al
    Serial position effects rapidly distinguish Alzheimer's from frontotemporal dementia.
    J Neurol. 2019 Dec 5. pii: 10.1007/s00415-019-09662.
    >> Share

    November 2019
  42. WANG X, Mao Z, Ling Z, Yu X, et al
    Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials.
    J Neurol. 2019 Nov 23. pii: 10.1007/s00415-019-09644.
    >> Share

    October 2019
  43. DOORDUIJN AS, de van der Schueren MAE, van de Rest O, de Leeuw FA, et al
    Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
    J Neurol. 2019 Oct 8. pii: 10.1007/s00415-019-09561.
    >> Share

    September 2019
  44. DE SIMONE MS, De Tollis M, Fadda L, Perri R, et al
    Lost or unavailable? Exploring mechanisms that affect retrograde memory in mild cognitive impairment and Alzheimer's disease patients.
    J Neurol. 2019 Sep 30. pii: 10.1007/s00415-019-09559.
    >> Share

    May 2019
  45. PERRY DC, Datta S, Miller ZA, Rankin KP, et al
    Factors that predict diagnostic stability in neurodegenerative dementia.
    J Neurol. 2019 May 17. pii: 10.1007/s00415-019-09362.
    >> Share

    March 2019
  46. MANUEL AL, Foxe D, Bradshaw N, Cordato NJ, et al
    Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia.
    J Neurol. 2019 Mar 5. pii: 10.1007/s00415-019-09261.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016